Summary
JPMorgan Chase & Co. (JPM) filed a Form 8-K on December 6, 2007, primarily to disclose an exhibit. The key exhibit is a tax opinion from Davis Polk & Wardwell concerning specific financial instruments: 7.00% (equivalent to 14.00% per annum) Reverse Exchangeable Notes due June 10, 2008, which are linked to the common stock of Ceradyne, Inc. This filing does not contain new financial results or significant operational updates for JPM itself. Instead, it pertains to a specific structured financial product offered by the company. Investors interested in these particular notes should review the tax opinion for its implications. The filing itself serves as a record of the tax advice received for these notes.
Key Highlights
- 1JPM filed an 8-K on December 6, 2007.
- 2The filing's primary purpose is to report an exhibit.
- 3The exhibit is a tax opinion from Davis Polk & Wardwell.
- 4The tax opinion relates to 7.00% Reverse Exchangeable Notes due June 10, 2008.
- 5These notes are linked to the common stock of Ceradyne, Inc.
- 6The filing is not a financial results announcement but rather relates to a specific product.